default image

Urologie

With emergency ambulance

Information and services of the department

  • Number of inpatient cases: 38

Zusätzlich wurden 6 Hybrid-DRG-Fälle erbracht: L17N 5 L20M 1

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 18
Hyperplasia of prostate (N40) 5
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) not specified
Benign neoplasm of urinary organs (D30.1) not specified
Calculus of kidney and ureter - Calculus of kidney (N20.0) not specified
Cystitis (N30.0) not specified
Cystitis (N30.2) not specified
(N30.88) not specified
Other disorders of bladder - Bladder-neck obstruction (N32.0) not specified
Other disorders of urinary system - Urinary tract infection site not specified (N39.0) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.2) 31
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 22
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 6
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 4
Examination of the ureter by endoscopy (1-665) 0
Additional information for investigations (1-999.2x) 0
Surgical removal or destruction of (diseased) tissue in the kidney (5-552.2) 0
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 0
Surgical removal or destruction of diseased tissue in the urethra (5-582.1) 0
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) 0

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
50 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
41 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
41 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks
Doctoral supervision
No. Training in other healing professions Comment
HB17 Auxiliary nurse (m/f)
HB19 Nursing professionals
HB07 Surgical technical assistant (m/f)

Gabriele Nauke

Sekretariat der Klinikgeschäftsführung

Phone: 03496 -52-1100
Mail: ed.tiehdnuseg-soileh@ekuaN.eleirbaG

Barbara Kromer

Leiterin Patientenmanagement/Medizincontrolling

Phone: 03496 -52-1127
Mail: ed.tiehdnuseg-soileh@remorK.arabraB

Tobias Spotka

Klinikgeschäftsführer

Phone: 03496 -52-1100
Mail: ed.tiehdnuseg-soileh@aktopS.saiboT

Barbara Kromer

Leiterin Patientenmanagement/ Medizincontrolling

Phone: 03496 -52-1127
Mail: ed.tiehdnuseg-soileh@remorK.arabraB

Prof. Dr. med. Peter Trommler

Vorsitzender

Phone: 03496 -52-1251
Mail: ed.tiehdnuseg-soileh@relmmorT.reteP

Dipl.-Pharm. Annedore Staack

Leiterin Zentralapotheke

Phone: 03921 -96-1200
Mail: ed.tiehdnuseg-soileh@kcaatS.erodennA